Tempest Therapeutics logo

Tempest Therapeutics

TPST | NASDAQ
Chart Builder DCF Calculator
$0.50
-$0.03 (-6.23%)
At close: Oct 30, 2026, 4:00 PM ET
-6.23%

Rating

Updated: Oct 30, 2026
19.2
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $8.37M
1D Range
0.50 0.52
52W Range
0.50 10.18

Valuation (TTM)

PE -0.11
PB -7.68
EV/EBITDA -0.38

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $7.00
Loading financial charts...

Profile

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highligh...

Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Nov 12, 2012
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$7.00
Upside
+1300.00%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.